EUVIMEDEUVIMED entdecken
Crossref

XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa And Latin America

Cardiovascular Research Prove Journal · 2017

DOI: 10.21608/cvrepj.2017.352431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research Prove Journal, 2017.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2017). XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa And Latin America. Cardiovascular Research Prove Journal. https://doi.org/10.21608/cvrepj.2017.352431

Vancouver

XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa And Latin America. Cardiovascular Research Prove Journal. 2017. doi:10.21608/cvrepj.2017.352431

BibTeX
@article{euvimed2017,
  title = {XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa And Latin America},
  journal = {Cardiovascular Research Prove Journal},
  year = {2017},
  doi = {10.21608/cvrepj.2017.352431}
}
Kostenlos starten →